Article
TP53 mutations predict poor prognosis in diffuse large B-cell lymphoma: A single-center study
2025-10-28
Abstract excerpt
<title>Abstract</title> <p> Evidence linking <italic>TP53</italic> mutations to survival outcome and treatment efficacy in diffuse large B-cell lymphoma (DLBCL) remains limited. In this retrospective cohort of 436 newly diagnosed DLBCL patients, <italic>TP53</italic> mutations were independent prognostic factors for poor overall survival (OS) and progression-free survival (PFS) (both <italic>P</italic> <...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0d53d3b0-58d1-5ba3-ad9e-06a09f0f268f
- DOI
- 10.21203/rs.3.rs-7797367/v1
